What is the recommended intravenous atropine dosing regimen for organophosphate poisoning in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Atropine Dosing for Organophosphate Poisoning

For life-threatening organophosphate poisoning, start with an initial IV bolus of 2-3 mg in adults (0.02 mg/kg in children), then double the dose every 5 minutes until full atropinization is achieved, which may require cumulative doses of 10-50+ mg in the first few hours. 1, 2

Initial Dosing Strategy

The 2023 American Heart Association guidelines provide the most authoritative dosing framework 1:

Adults

  • Initial bolus: 2-3 mg IV 2
  • Escalation protocol: Double the dose every 5 minutes until atropinization achieved 1
  • Expected cumulative dose: 10-20 mg in the first 2-3 hours for adequate symptom control 3
  • Maximum reported: Up to 50 mg in 24 hours may be necessary 3

Children

  • Initial bolus: 0.02 mg/kg IV 2
  • Escalation: Follow same doubling protocol as adults 1
  • For symptomatic children <1 year: minimum 0.5 mg dose 4
  • For children >1 year: full adult dosing may be appropriate when severe 4

Endpoints of Atropinization

Stop escalating when ALL of the following are achieved 1:

  • Clear chest on auscultation (no bronchorrhea/bronchospasm)
  • Heart rate >80 bpm
  • Systolic blood pressure >80 mmHg
  • Drying of secretions

Critical pitfall: Do NOT use pupil size as an endpoint—atropine does not reverse nicotinic effects like paralysis, only muscarinic symptoms 1, 3.

Maintenance Therapy

Once atropinized, transition to continuous IV infusion 1:

  • Maintenance rate: Approximately 0.005-0.06 mg/kg/hour depending on severity 5
  • Titrate to maintain clinical endpoints above
  • Duration typically 9-10 days but can extend to 24 days 6

Key insight: Patients with complete RBC-AChE inhibition require up to 0.06 mg/kg/hour, while those with 10-30% enzyme activity need only ~0.005 mg/kg/hour 5.

Why Aggressive Dosing is Essential

The evidence strongly supports rapid, high-dose atropinization 7:

  • Modern protocols achieving mean doses within 30 minutes show improved outcomes compared to older slow-escalation regimens
  • 15 of 24 current authoritative sources now recommend dose-doubling protocols 7
  • Early aggressive atropinization improved survival in clinical trials 1

Common error: Underdosing atropine is far more dangerous than overdosing. Atropine toxicity (delirium, hallucinations) is generally well-tolerated and reversible, whereas inadequate atropinization leads to respiratory failure and death 4, 8.

Adjunctive Therapy

While atropine is the cornerstone, also administer:

  • Pralidoxime: Reasonable to give for organophosphate poisoning (Class 2a recommendation) 1
  • Benzodiazepines: Diazepam or midazolam for seizures/agitation (Class 1 recommendation) 1
  • Early intubation: For life-threatening cases (Class 1 recommendation) 1

Special Considerations

Coronary artery disease: Limit total atropine to 0.03-0.04 mg/kg to minimize cardiac risk 2, though this may be inadequate for severe poisoning—prioritize survival over ischemia risk.

Late arrhythmias: Malignant arrhythmias can occur when S-hyoscyamine levels drop below 2.5 nmol/L, often without obvious cholinergic signs—maintain adequate atropine levels throughout 5.

Titrated vs. ad hoc dosing: Structured titration protocols reduce atropine toxicity (delirium 1% vs 35%, hallucinations 1% vs 35%) without compromising mortality outcomes 8. Use a monitoring sheet to guide dosing rather than arbitrary high-dose regimens.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.